whether Lantus increases cancer risk
July 2009
We are working on the following article about Lantus and cancer. It is being considered by our Peer-Review panel, Specialty Consultants, and our Panel that refines the final recommendations. It is posted here now to give you a preview of what we may publish in a few days when it is final. If you have comments or suggestions on this draft article, please tell us right away.
Patients are asking whether Lantus increases cancer risk.
This comes from some recent European studies that show a higher cancer risk in patients using Lantus (insulin glargine) compared to other insulins.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote